Monkey eyeing sampling platform

CREATE-NEO: Alejandro Villasante-Tezanos, PhD
UTMB Team


Dr. Villasante-Tezanos_utmbAlejandro Villasante-Tezanos is assistant professor for the Department of Preventive Medicine and Population Health at UTMB. He studied at the Universidad Miguel Hernandez in Elche, Spain, where he obtained his bachelor and master’s degrees in Statistics. He worked as an educator and in industry for several years until he returned to academia to obtain a second master’s and his PhD degree in Statistics at the University of Kentucky, working as a biostatistician for this institution for almost five years. He serves as statistical consultant at the Galveston National Laboratory and is a statistical advisor for the Institute for Translational Science at UTMB serving in the Clinical Trials Studio committee. He has collaborated for a wide spectrum of grants and peer-reviewed publications with different roles including first author. He has also presented at international statistical meetings and has broad experience in statistical methods including case reports, survey analyses, microarray analyses, clinical trials and observational studies.

Dr. Villasante has demonstrated expertise in the development of new methods, especially in multivariate analyses. He studied a nonparametric composite test which can be utilized when a dimension is large and the sample size is small, with practical applications for clinical electrophysiology (EEG). Moreover, this nonparametric composite test may have utility in microarray and genetic analyses.

More information
Email: alvillas@utmb.edu


CREATE-NEO members

The Centers for Research in Emerging Infectious Disease (CREID) is a coordinated network with centers in regions around the globe where emerging and re-emerging infectious disease outbreaks are likely to occur. Multidisciplinary teams of investigators will conduct pathogen/host surveillance, study pathogen transmission, pathogenesis and immunologic responses in the host, and will develop reagents and diagnostic assays for improved detection for important emerging pathogens and their vectors.


NIAID launched the CREID Network in 2020.This website is run by CREATE-NEO, a member of the CREID Network independent of NIH/NIAID.